Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
2.175
+0.005 (0.23%)
Apr 28, 2025, 11:47 AM EDT - Market open
Acelyrin Market Cap
Acelyrin has a market cap or net worth of $219.04 million as of April 28, 2025. Its market cap has decreased by -60.93% in one year.
Market Cap
219.04M
Enterprise Value
-222.04M
1-Year Change
-60.93%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $219.04M, a decrease of -86.87%. That is a compound annual growth rate of -64.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 218.54M | -30.63% |
| Dec 31, 2024 | 315.02M | -56.62% |
| Dec 29, 2023 | 726.15M | -56.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |